Categories: News

Bravado Health launches new patient discharge product

WEST PALM BEACH, Fla., April 9, 2019 /PRNewswire/ — Bravado Health, a premier health IT company, today unveils the first core product of its new patient engagement platform with the launch of Ayva Discharge.

Ayva Discharge is the next generation of Bravado Health’s popular point-of-care suite, ScriptRx. The first core product to launch within the Ayva engagement platform, Ayva Discharge allows healthcare organizations to efficiently discharge patients with high-quality materials — including evidence-based instructions, electronic prescriptions, and practical referrals — all from a convenient web-based application.

The launch of Ayva Discharge marks an important milestone for Bravado Health. “We have been providing discharge solutions for over 20 years and this launch not only moves our platform to the cloud, it represents a significant product upgrade,” said David Dietze, CEO of Bravado Health. “Ayva Discharge functions as an independent patient discharge suite, but it can also be combined with other Ayva solutions to seamlessly connect the entire post-visit patient experience with the original point-of-care.”

The Ayva platform will initially focus on reimagining the post-visit patient experience. The platform cornerstone is an AI-powered virtual assistant named Ayva. Ayva will highlight the practical applications of artificial intelligence in healthcare and further cement Bravado Health as a leading provider of health IT solutions.

Ayva Engage, the flagship product within the Ayva platform, will launch in June 2019. Ayva Engage intelligently automates the process of engaging patients, coordinating care and connecting the entire post-visit experience.

Learn more at ayvacares.com/ayva-discharge.

About Bravado Health

Bravado Health was founded by physicians and engineers in 1998 to streamline the discharge process. From its origin in discharge technology, Bravado Health expanded its portfolio to patient engagement and web-based applications. Today, Bravado Health provides solutions for some of the nation’s most recognizable and innovative healthcare organizations. Bravado Health’s newest platform, Ayva, extends the reach of providers beyond the point-of-care to securely connect with patients post-visit, bridging gaps in the continuum of care. Learn more at bravadohealth.com.

Contact: Shane Andreasen, (561) 877-5238, shane@bravadohealth.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/bravado-health-launches-new-patient-discharge-product-300826254.html

SOURCE Bravado Health

Staff

Recent Posts

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…

3 hours ago

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …

3 hours ago

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…

3 hours ago

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…

3 hours ago

Facelift + Eyelid Surgery in Tampa: Gruber Plastic Surgery Shares 2025 Planning Insights on Natural Results and Popular Procedure Pairings

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national…

3 hours ago

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…

6 hours ago